Article

Living With Terminal Cancer

Author(s):

It's not always easy to keep on living when you've been told that you are dying.

I was diagnosed with lung cancer at an early stage when a cure was a distinct possibility. However, despite aggressive treatment — a lower left lobectomy followed by four rounds of chemotherapy — my cancer soon recurred. Three years after diagnosis I was restaged to 4 and advised that I had only three to five months left to live. Upon my request, I was referred to a thoracic social worker and at my first appointment I asked for help coming to terms with the fact that I was dying — I believe my exact words were, "Help me learn how to die."

Well, thanks to an experimental therapy (three of them, in point of fact), I didn’t die then. More than seven years later, I still see the same thoracic social worker every few weeks with the focus now on surviving. We talk at length about the problems specific to advanced cancer — the challenges of getting on with life when your prognosis is less than encouraging.

For instance; it takes real guts to get up in the morning when you know that your statistical probability of surviving the next five years is a dismal 1 percent, the figure given for stage 4 lung cancer. Rather than having PTSD, my social worker and I have agreed that those of us with terminal illnesses likely suffer from OTSD, or ongoing traumatic stress disorder.

However, I continue to count my blessings and I manage the day-to-day with a mix of faith, hope and a real can-do attitude. Faith in medical science and my oncology team, hope that I will respond to available treatments with more coming down the pike and the strong belief that, against the odds, I really can keep on surviving.

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Related Content